First Trust Mid Cap Growth AlphaDEX FundFNY

First Trust’s FNY isn’t a fund that promises to relative strength; it promises to track a mid-cap growth index after the index itself has been sliced, diced and reassembled by a rules engine it calls AlphaDEX. The ETF’s mandate is simple: own the mid-cap growth stocks that score highest on a proprietary screen and then charge 0.60% per year for owning them. There is no human discretion, no stock-picking flair, and-unless you count the screen’s output as genius-no edge. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/fny)

The fund’s top holdings are whatever the screen spits out on the day the index rebalances, which is why you will often find the same familiar mid-cap names rotating in and out like extras in a low-budget sequel. Concentration risk is real: the top ten positions can swallow as much as a quarter of the portfolio, so if the screen suddenly fancies a laggard, your exposure follows. Liquidity is adequate but not stellar; FNY trades on Nasdaq with volumes that ebb and flow with the mid-cap mood, not with any special insight the wrapper claims to possess. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

FNY’s expense ratio is 0.60%, a figure that sounds modest until you remember that it is buying a mechanical basket and charging for the privilege of owning it. The fund’s prospectus and regulatory filings are filed under SEC EDGAR, where they sit alongside thousands of other boilerplate documents that promise “growth” but deliver a screen-filtered approximation of the S&P MidCap 400 Growth Index. There is no performance promise, only a promise to follow the screen and to charge 0.60% for doing so. (source: SEC EDGAR fund search, https://www.sec.gov/edgar/search/#/q=FNY)

If you want to see where FNY sits versus the broader market, the Nasdaq quote page shows the ticker’s price, volume and basic stats, but it offers no insight into whether the screen has worked or merely shuffled names. The chart itself is just the mechanical output of a rules engine and a fee schedule; the real story is the gap between the wrapper’s thematic promise and the unglamorous basket inside. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/fny)

What changed today? Nothing specific in the evidence set suggests a catalyst or a filing surprise; FNY’s daily machinations are driven by the AlphaDEX screen and the market’s mid-cap growth mood, neither of which leaves a trace in the supplied sources. The fund’s structure, fee and holdings are unchanged by the calendar; only the screen’s output shifts, and that shift is not disclosed in the sources provided. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/; Nasdaq, https://www.nasdaq.com/market-activity/etf/fny)

What remains unproven is whether FNY’s screen actually adds value or merely repackages the mid-cap growth universe at a cost. The evidence shows only the fund’s rules, fee and venue, not its performance edge. Until the fund’s prospectus or a third-party study supplies a clear backtest or live relative strength, FNY remains a mechanical wrapper with a fee, not a stock-picking triumph. (source: SEC EDGAR fund search, https://www.sec.gov/edgar/search/#/q=FNY)